Results 201 to 209 of about 77,701 (209)

Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond

Nature Reviews Drug Discovery, 2012
P Mark Hogarth
exaly  

Molecular Mechanism of Angiotensin II Type 1 Receptor Blocker as an Inverse Agonist

Journal of Cardiac Failure, 2007
Noritaka Yasuda, Hiroshi Akazawa, Shin-Ichiro Miura, Yingjie Qin, Kaoru Ito, Keijiro Saku, Issei Komuro   +6 more
openaire   +1 more source

Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes

Nature Reviews Drug Discovery, 2011
Uwe Rudolph
exaly  

EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial

Lancet, The, 2014
Andrew S C Rice, Gary R Cutter
exaly  

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

New England Journal of Medicine, 2001
exaly  

New Molecular Classifications of Breast Cancer

Ca-A Cancer Journal for Clinicians, 2009
exaly  

Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction

Lancet, The, 1994
exaly  

Beyond fluorodeoxyglucose: Molecular imaging of cancer in precision medicine

Ca-A Cancer Journal for Clinicians
exaly  

Personalized care for patients with EGFR‐mutant nonsmall cell lung cancer: Navigating early to advanced disease management

Ca-A Cancer Journal for Clinicians
exaly